Face masks are still required to be worn while at the facility, even if you have been fully vaccinated. Thank you for your understanding!
CORONAVIRUS ALERT: WNY BloodCare is continually monitoring information during this outbreak. Please visit our News section for the latest updates
340B Program - This program was created by Congress in 1992 as part of the Veteran’s Health Care Act. It allows Hemophilia Treatment Centers to purchase clotting factor at a discount for their patients.
The most important benefit of the 340B Program is that it provides funding for our Hemophilia Treatment Center (HTC). These funds make it possible for us to serve our patients with the highest level of quality care. The funds from our 340B factor sales help us provide full comprehensive care and specialty coagulation laboratory services all in one sight. Having pharmacy services integrated with clinical care maintains continuity and promotes better health outcomes.
Factor Distribution – In addition to providing factor infusions in our Center, we are able to ship factor and supplies to our patients on our Home Therapy program at no charge to our patients. Our in-house pharmacy coordinates all factor distribution and can be reached at (716) 218-4006.